에서 실시간으로 운영 중이에요! 자세히 알아보기
LMRI 아이콘

Lumexa Imaging Holdings

10.78 USD
0.00
0%
장 마감 시점 업데이트됨 10월 16일 PM 4:00 EDT
1일
0%
5일
2.08%
1개월
-7.47%
3개월
-3.75%
6개월
18.98%
연초 이후
-38.58%
1년
-41.79%
5년
-41.79%
10년
-41.79%
 

소개: Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities, including MRI, CT, PET, X-ray, ultrasound, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated by the Outpatient segment, which performs imaging studies and provides radiologists' interpretations of those studies.

직원 수: 4,335

뉴스

긍정적
중립
부정적
투자 심리 3개월
긍정적 37.5%
중립 62.5%
부정적 0%
긍정적
Zacks Investment Research
지난달
Lumexa (LMRI) Upgraded to Buy: Here's What You Should Know
Lumexa (LMRI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Lumexa (LMRI) Upgraded to Buy: Here's What You Should Know
중립
GlobeNewsWire
지난달
Lumexa Imaging Announces Participation in Upcoming Investor Conferences
RALEIGH, N.C., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging Holdings, Inc. (“Lumexa Imaging”) (Nasdaq: LMRI), one of the nation's largest providers of outpatient imaging services, announced today that Caitlin Zulla, CEO, and Tony Martin, CFO, will participate in the following upcoming investor conferences: Wells Fargo 21st Annual Healthcare Conference, held in Boston, including a fireside chat at 3:00 PM ET and one-on-one meetings with Caitlin Zulla and Tony Martin on September 9, 2026.
Lumexa Imaging Announces Participation in Upcoming Investor Conferences
긍정적
Zacks Investment Research
지난달
Wall Street Analysts See a 36.88% Upside in Lumexa (LMRI): Can the Stock Really Move This High?
The consensus price target hints at a 36.9% upside potential for Lumexa (LMRI). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Wall Street Analysts See a 36.88% Upside in Lumexa (LMRI): Can the Stock Really Move This High?
중립
Seeking Alpha
2개월 전
Lumexa Imaging Holdings, Inc. (LMRI) Q2 2026 Earnings Call Transcript
Lumexa Imaging Holdings, Inc. (LMRI) Q2 2026 Earnings Call Transcript
Lumexa Imaging Holdings, Inc. (LMRI) Q2 2026 Earnings Call Transcript
긍정적
MarketBeat
2개월 전
Lumexa Imaging Q2 Earnings Call Highlights
Lumexa Imaging NASDAQ: LMRI reported second-quarter revenue growth, higher advanced-imaging volumes and a return to profitability, while narrowing its full-year adjusted EBITDA outlook and reiterating revenue and adjusted earnings-per-share guidance.
Lumexa Imaging Q2 Earnings Call Highlights
중립
GlobeNewsWire
2개월 전
Lumexa Imaging Announces Second Quarter 2026 Results
RALEIGH, N.C., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation's largest providers of outpatient imaging services, today reported results for the second quarter ended June 30, 2026, and updated its full year 2026 outlook.
Lumexa Imaging Announces Second Quarter 2026 Results
중립
GlobeNewsWire
2개월 전
Lumexa Imaging Announces Second Quarter 2026 Earnings Conference Call Date
RALEIGH, N.C., July 29, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation's largest providers of outpatient imaging services, today announced it will release its second quarter 2026 financial and operational results after market close on Wednesday, August 12, 2026.
Lumexa Imaging Announces Second Quarter 2026 Earnings Conference Call Date
중립
Zacks Investment Research
2개월 전
4 Medical Products Stocks Poised to Win Despite Industry Headwinds
Terumo, QuidelOrtho, Lumexa Imaging and BrainsWay are tackling industry headwinds through innovation, pricing and execution as healthcare demand stays resilient.
4 Medical Products Stocks Poised to Win Despite Industry Headwinds
긍정적
Zacks Investment Research
3개월 전
Wall Street Analysts Think Lumexa (LMRI) Could Surge 44.08%: Read This Before Placing a Bet
The mean of analysts' price targets for Lumexa (LMRI) points to a 44.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Wall Street Analysts Think Lumexa (LMRI) Could Surge 44.08%: Read This Before Placing a Bet
긍정적
Zacks Investment Research
3개월 전
Wall Street Analysts Believe Lumexa (LMRI) Could Rally 73.25%: Here's is How to Trade
The consensus price target hints at a 73.3% upside potential for Lumexa (LMRI). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Wall Street Analysts Believe Lumexa (LMRI) Could Rally 73.25%: Here's is How to Trade
Lightweight Charts™를 사용해 가격 차트를 구현했어요.